Literature DB >> 9635837

The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.

L Wyld1, M W Reed, N J Brown.   

Abstract

Photodynamic therapy (PDT) is a cancer treatment based on the interaction of light and a photosensitizing chemical. The photosensitizer protoporphyrin IX (PpIX) is generated via the haem biosynthetic pathway after administration of aminolaevulinic acid (ALA). The cellular microenvironment of tumours is hypoxic and acidotic relative to normal tissue, which may influence PpIX generation and compromise PDT efficacy. This study used bladder cancer cells, incubated with ALA at various oxygen tensions and H+ ion concentrations, and assessed the effects on PpIX generation and PDT sensitivity. PpIX production was reduced at 0%, 2.5% (19 mmHg) and 5% (38 mmHg) oxygen compared with that at 21% (160 mmHg) oxygen (0.15, 0.28 and 0.398 ng microg(-1) protein compared with 0.68 ng microg(-1) respectively; P < 0.05). The response to PDT was abolished by hypoxia, as a result of both reduced PpIX synthesis and reduced PDT toxicity. PpIX production was greater at pH 7.0 and 6.5 (0.75 and 0.66 ng microg(-1)) compared with that at pH 7.4 and 5.5 (0.41 and 0.55 ng microg(-1) respectively). PDT cytotoxicity was enhanced at lower pH values. These results suggest that ALA-induced PDT may be inhibited by hypoxia due to reduced intrinsic PpIX synthesis. Acidosis may slightly enhance the efficacy of ALA-induced PDT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635837      PMCID: PMC2150064          DOI: 10.1038/bjc.1998.265

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation.

Authors:  B W Henderson; A C Miller
Journal:  Radiat Res       Date:  1986-11       Impact factor: 2.841

2.  Photodynamic therapy-induced hypoxia in rat tumors and normal tissues.

Authors:  B D Hirsch; N C Walz; B E Meeker; M R Arnfield; J Tulip; M S McPhee; J D Chapman
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

3.  Uroporphyrinogen decarboxylase from mouse spleen.

Authors:  G Romeo; E Y Levin
Journal:  Biochim Biophys Acta       Date:  1971-02-23

4.  Interaction of the bioreductive drug SR 4233 and photodynamic therapy using photofrin in a mouse tumor model.

Authors:  P Baas; H Oppelaar; M Stavenuiter; N van Zandwijk; F A Stewart
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-10-20       Impact factor: 7.038

5.  Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.

Authors:  V H Fingar; T S Mang; B W Henderson
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

Review 6.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

7.  The effect of photodynamic therapy on tumor oxygenation.

Authors:  M W Reed; A P Mullins; G L Anderson; F N Miller; T J Wieman
Journal:  Surgery       Date:  1989-07       Impact factor: 3.982

8.  Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.

Authors:  L Wyld; J L Burn; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.

Authors:  I J Stratford; M A Stephens
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-04       Impact factor: 7.038

10.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.

Authors:  F Cairnduff; M R Stringer; E J Hudson; D V Ash; S B Brown
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  16 in total

1.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

2.  An Overview Of Photosubstitution Reactions Of Ru(II) Imine Complexes And Their Application In Photobiology And Photodynamic Therapy.

Authors:  Jessica K White; Russell H Schmehl; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-06-18       Impact factor: 2.545

3.  Review of Neurosurgical Fluorescence Imaging Methodologies.

Authors:  Brian W Pogue; Summer Gibbs-Strauss; Pablo A Valdés; Kimberley Samkoe; David W Roberts; Keith D Paulsen
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-05       Impact factor: 4.544

4.  Photoinduced interactions of two dirhodium complexes with d(GTCGAC)2 probed by 2D NOESY.

Authors:  Alycia M Palmer; Jessica D Knoll; Claudia Turro
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

5.  Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynecological lesions of intraepithelial form.

Authors:  Paul A McCarron; Ryan F Donnelly; Brendan F Gilmore; A David Woolfson; Raymond McClelland; Agnieszka Zawislak; John H Price
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

Review 6.  Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis.

Authors:  Hung Wei Lai; Taku Nakayama; Shun-Ichiro Ogura
Journal:  Int J Clin Oncol       Date:  2020-09-01       Impact factor: 3.402

Review 7.  Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.

Authors:  Aaron J Sorrin; Mustafa Kemal Ruhi; Nathaniel A Ferlic; Vida Karimnia; William J Polacheck; Jonathan P Celli; Huang-Chiao Huang; Imran Rizvi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.421

Review 8.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

9.  A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia.

Authors:  W M Gallagher; L T Allen; C O'Shea; T Kenna; M Hall; A Gorman; J Killoran; D F O'Shea
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

10.  Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation.

Authors:  L Wyld; M Tomlinson; M W R Reed; N J Brown
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.